|
Index of reports
> Cases resulting in hospitalization (92)
> Cases with Vomiting (7)
Below is the selection of adverse event reports related to Epivir (Lamivudine) that includes cases resulting in hospitalization where reactions include vomiting.
Adverse event in 39 year old male receiving Epivir (Lamivudine)
Reported by a physician from Japan on 2007-06-26
Patient: 39 year old male
Adverse reactions / side effects: Vomiting, Neurogenic Bladder, Nasopharyngitis, Nausea, Costovertebral Angle Tenderness, Urinary Tract Infection, Pyrexia, Epilepsy, Eating Disorder, Convulsion, Ascites, Blood Potassium Decreased, Tenderness, Pyuria, Pyelonephritis
Adverse event resulted in: hospitalization
Suspect drug(s):
Epivir
Dosage: 150mg twice per day
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 1996-12-18
End date: 1997-03-13
Epivir
Dosage: 150mg twice per day
Administration route: Oral
Start date: 1998-07-10
End date: 1999-10-31
Epivir
Administration route: Oral
Start date: 1999-11-01
End date: 2003-03-31
Epivir
Dosage: 150mg twice per day
Administration route: Oral
Start date: 2003-04-01
End date: 2003-04-26
Epivir
Dosage: 150mg twice per day
Administration route: Oral
Start date: 2004-07-28
Ziagen
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 2003-04-27
End date: 2003-12-24
Ziagen
Dosage: 300mg twice per day
Administration route: Oral
Start date: 2004-05-28
End date: 2004-06-29
Ziagen
Dosage: 300mg twice per day
Administration route: Oral
Start date: 2004-12-17
Kaletra
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 2004-06-30
End date: 2006-11-23
Other drugs received by patient: Kaletra
Adverse event in 37 year old male receiving Epivir (Lamivudine)
Reported by a health professional (non-physician/pharmacist) from Japan on 2007-04-02
Patient: 37 year old male
Adverse reactions / side effects: Vomiting, Overdose, Depressed Level of Consciousness, Suicide Attempt, Depression, Lipodystrophy Acquired
Adverse event resulted in: hospitalization
Suspect drug(s):
Stocrin Caps
Dosage: normal dosage 600 mg daily
Administration route: Oral
Indication: HIV Infection
Start date: 2001-04-01
End date: 2005-11-15
Stocrin Caps
Administration route: Oral
Start date: 2005-11-16
End date: 2005-11-16
Zerit
Dosage: stopped in apr-2005, restarted on an unspecified date
Administration route: Oral
Indication: HIV Infection
Start date: 2001-04-01
End date: 2005-11-16
Viread
Administration route: Oral
Indication: HIV Infection
Start date: 2005-04-01
End date: 2005-11-15
Viread
Administration route: Oral
Start date: 2005-11-16
End date: 2005-11-16
Epivir
Dosage: 300 mg daily normal daily dosage stopped in may-2001, restarted on an unspecified date
Administration route: Oral
Indication: HIV Infection
Start date: 2001-04-01
End date: 2005-11-15
Epivir
Administration route: Oral
Start date: 2005-11-16
End date: 2005-11-16
Other drugs received by patient: Rhythmy; Valtrex
Adverse event in 36 year old male receiving Epivir (Lamivudine)
Reported by a physician from Japan on 2007-04-02
Patient: 36 year old male
Adverse reactions / side effects: Vomiting, Intentional Overdose, Depressed Level of Consciousness, Suicide Attempt, Depression, Lipodystrophy Acquired
Adverse event resulted in: hospitalization
Suspect drug(s):
Epivir
Dosage: 300mg per day
Administration route: Oral
Indication: HIV Infection
Start date: 2001-04-01
Stocrin
Dosage: 600mg per day
Administration route: Oral
Indication: HIV Infection
Start date: 2001-04-01
Viread
Dosage: 300mg per day
Administration route: Oral
Indication: HIV Infection
Start date: 2005-04-01
Zerit
Administration route: Oral
Indication: HIV Infection
Start date: 2001-04-01
End date: 2005-03-01
Adverse event in 32 year old male receiving Epivir (Lamivudine)
Reported by a individual with unspecified qualification from France on 2007-03-21
Patient: 32 year old male
Adverse reactions / side effects: Weight Decreased, Abdominal Pain, Metabolic Acidosis, Blood Creatine Phosphokinase Increased, Vomiting, Alanine Aminotransferase Increased, Respiratory Alkalosis, Lactic Acidosis, Myalgia, Heart Rate Increased, Aspartate Aminotransferase Increased
Adverse event resulted in: hospitalization
Suspect drug(s):
Epivir
Indication: HIV Infection
Lopinavir (Formulation Unknown) (Lopinavir)
Indication: HIV Infection
Stavudine
Indication: HIV Infection
Other drugs received by patient: CO-Trimoxazole
Adverse event in 46 year old male receiving Epivir (Lamivudine)
Reported by a physician from Japan on 2007-03-05
Patient: 46 year old male
Adverse reactions / side effects: Back Pain, Abdominal Pain, Vomiting, Lymphadenopathy, Nausea, Musculoskeletal Pain, Abasia, Muscular Weakness, Hypoaesthesia, Renal Impairment, Malaise, Fatigue, Diarrhoea, Anorexia, Lipoatrophy, Decreased Appetite
Adverse event resulted in: hospitalization
Suspect drug(s):
Zerit
Administration route: Oral
Indication: HIV Infection CDC Group IV Subgroup C1
Start date: 1997-08-04
End date: 2006-05-10
Epivir
Dosage: restarted on 16-feb-2004 to 10-may-2006.
Administration route: Oral
Indication: HIV Infection CDC Group IV Subgroup C1
Start date: 1997-03-31
End date: 2000-02-17
Crixivan
Administration route: Oral
Indication: HIV Infection CDC Group IV Subgroup C1
Start date: 1997-08-04
End date: 1997-09-18
Crixivan
Administration route: Oral
Start date: 1997-09-21
End date: 1999-01-28
Other drugs received by patient: Stadol; Prochlorperazine; Voltaren; Buprenorphine HCL; Magnesium Sulfate; Vitamins; Zovirax; Diflucan; Baktar; Videx; Fungizone; Retrovir; Hivid; Solita-T NO. 3; Buscopan; Folic Acid; Resplen; Clarithromycin; Viracept; Invirase; Norvir; Ziagen; Neurotropin; Hyaluronic Acid; Bendrofluazide; CO-Dydramol; Stocrin; Xylocaine; Amicaliq; Viramune
Adverse event in male receiving Epivir (Lamivudine)
Reported by a consumer/non-health professional from France on 2007-01-19
Patient: male
Adverse reactions / side effects: Paresis Cranial Nerve, Vomiting, Visual Acuity Reduced, Neoplasm, Somnolence, Strabismus, Papilloedema, Diplopia, Pinealoblastoma, Fatigue, Drug Exposure During Pregnancy, Hydrocephalus
Adverse event resulted in: hospitalization
Suspect drug(s):
Retrovir
Administration route: Oral
Indication: Antiviral Prophylaxis
Start date: 1998-04-28
End date: 1998-06-05
Epivir
Administration route: Oral
Indication: Antiviral Prophylaxis
Start date: 1998-04-28
End date: 1998-06-05
Other drugs received by patient: Retrovir; Epivir; Retrovir; Clamoxyl
Adverse event in male receiving Epivir (Lamivudine)
Reported by a health professional (non-physician/pharmacist) from Japan on 2007-01-17
Patient: male
Adverse reactions / side effects: Vomiting, Dialysis, Intentional Overdose, Depressed Level of Consciousness, Depression, Lipodystrophy Acquired
Adverse event resulted in: hospitalization
Suspect drug(s):
Viread
Administration route: Oral
Indication: HIV Infection
Start date: 2005-04-01
Stocrin
Administration route: Oral
Indication: HIV Infection
Start date: 2001-04-01
Epivir
Administration route: Oral
Indication: HIV Infection
Start date: 2001-04-01
Stavudine
Administration route: Oral
Indication: HIV Infection
Start date: 2001-04-01
End date: 2005-03-01
|
